Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Base Positioning Wheelchair Hemiplegic

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03354949
Recruitment Status : Unknown
Verified November 2017 by Groupement Hospitalier Intercommunal du Vexin.
Recruitment status was:  Active, not recruiting
First Posted : November 28, 2017
Last Update Posted : November 28, 2017
Sponsor:
Information provided by (Responsible Party):
Groupement Hospitalier Intercommunal du Vexin

Brief Summary:
The investigators looked at the population of hemiplegic stroke participants hospitalized with GHIV : the investigators assessed the postural control of the participants of the chair using MCPAA, and assessed the pain of the participants while sitting in a wheelchair. The investigators then had to the participants try positioning equipment and then prescribed it once the choice was made. The investigators then reassessed postural control and wheelchair pain with this positioning equipment.

Condition or disease Intervention/treatment
Wheelchair Other: Measurement of sitting postural control of the adult (MCPAA)

Detailed Description:

For each hemiplegic participants with wheelchair user stroke, the investigators collect : date of birth, date of stroke, side of hemiplegia. The wheelchair propulsion mode, the degree of autonomy (FAC and Enjalber scales), the way bed - wheelchair transfers are made. Assessment of wheelchair pain in the spine and Ischia with EVA. Time to travel 10 meters in a wheelchair. Postural control of the wheelchair is evaluated by the MCPAA. The investigators then carry out tests of positioning equipment : backrest, cushion, form elements and belt. This material is tried for several days. If it is appropriate (improvement on the postural control and on the pains), otherwise another material is tried.

When the choice is made, the material is prescribed. The participant is seen again 3 months after the delivery of his personal material, and the same evaluation is redone.

Layout table for study information
Study Type : Observational
Actual Enrollment : 24 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Postural Wheelchair Control in Hemiplegic Stroke Patients
Actual Study Start Date : September 1, 2016
Estimated Primary Completion Date : March 1, 2018
Estimated Study Completion Date : March 1, 2018

Group/Cohort Intervention/treatment
Positioning hemiplegic.

Positioning all hemiplegic by stroke requiring a single wheelchair even at the exit of the SSR and hemiplegic patient with sequelae.

Measurement of sitting postural control of the adult (MCPAA). Assessment of wheelchair pain in the spine and ischia by a self-evaluation scale (EVA).

Propulsion speed of a wheelchair.

Other: Measurement of sitting postural control of the adult (MCPAA)

The Adult Seated Postural Control Measure 2.0 (MCPAA 2.0) is a clinical evaluation tool for sitting postural control of adult clients using a locomotion aid. It thus allows the evaluation of the two variables inherent to the postural control sit, the alignment of body segments and the influence between movement and posture.

It can also be used to evaluate the changes in seated postural control due to changes over time or to an adaptation of the sitting posture.

Assessment of wheelchair pain in the spine and ischia by a self-evaluation scale (EVA).

the speed of propulsion by a wheelchair.





Primary Outcome Measures :
  1. Study the improvement of the basin retroversion. [ Time Frame: Through study completion, an average of one year. ]
    The Adult Seated Postural Control Measure 2.0 (MCPAA 2.0) is a clinical evaluation tool for sitting postural control of adult clients using a locomotion aid. It thus allows the evaluation of the two variables inherent to the postural control sit, the alignment of body segments and the influence between movement and posture. It can also be used to evaluate the changes in seated postural control due to changes over time or to an adaptation of the sitting posture.


Secondary Outcome Measures :
  1. The tilt. [ Time Frame: Through study completion, an average of one year. ]

    Assessment of wheelchair pain in the spine and ischia by a self-evaluation scale (EVA). The self-evaluation scale (EVA) is used to assess participant pain.

    It is in the form of a straight line of 100 mm. This scale is composed on the reverse side of a horizontal line from "no pain" to "maximum pain imaginable". The left side corresponds to "no pain", the right end corresponds to "maximum pain imaginable". The participant indicates, with the cursor, his level of pain on the line. The pain score is displayed on the front of the scale.


  2. Propulsion speed. [ Time Frame: Through study completion, an average of one year. ]
    The propelling speed of the wheelchair.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 100 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Positioning of all hemiplegics by stroke requiring a wheelchair even punctual at the exit of the SSR compared to patients with hemiplegic sequelae.
Criteria

Inclusion Criteria:

  • Hemiplegia by stroke
  • Wheelchair user

Exclusion Criteria:

  • Two-handed propulsion of the wheelchair
  • Cognitive impairment preventing clinical examination

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03354949


Sponsors and Collaborators
Groupement Hospitalier Intercommunal du Vexin
Investigators
Layout table for investigator information
Principal Investigator: Nadine PELLIGRINI Groupe Hospitalier Intercommunal du Vexin
Layout table for additonal information
Responsible Party: Groupement Hospitalier Intercommunal du Vexin
ClinicalTrials.gov Identifier: NCT03354949    
Other Study ID Numbers: GHIV0117
First Posted: November 28, 2017    Key Record Dates
Last Update Posted: November 28, 2017
Last Verified: November 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Groupement Hospitalier Intercommunal du Vexin:
Wheelchair
Hemiplegia
Stroke
Postural control
Pain